Skip to main content

Table 1 Assessment per measurement moment

From: Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial

  Method T0 T1 T2 T3 T4 T5 T6 T7
Clinical Diagnostic Interview (SCID-I) Int X   X  
Depressive symptoms (HDRS) Int X   X X  
Peripartum depression (EPDS) SR   X X X   X X  
Anxiety (STAI) SR   X X X   X X  
Affect (I-PANAS-SF) SR   X X X   X X  
Attitudes (DAS) SR   X X X     
Daily hassles Int X   X X   X X  
Life events Int X   X X   X X  
Sociodemographic & -economic factors (Mind2Care) SR   X       
Substance use (Mind2Care) SR   X X X   X X  
Medication use Int X   X X   X X  
Medication adherence SR   X       
Medication beliefs SR   X       
Childhood trauma (CTQ) SR    X      
Quality of Life (EQ-5D-5L) SR   X X X   X X  
Health care consumption (TIC-P) SR   X   X   X X  
Pregnancy related outcomes CG      X    
Neural development (GM) ME        X  
Child behaviour (CBCL) SR         X
Cortisol (hair strands) BM   X    X   X  
Buccal swab BM   X      X  
Blood sample BM        X  
Meconium (SSRI concentration) BM      X    
Breast milk (SSRI concentration) BM      X    
  1. Int interview, SR self report, CG caregiver, BM biological materials, T0 pre-assesment, T1 baseline, T2 24 weeks of gestation, T3 36 weeks of gestation, T4 delivery, T5 4 weeks postpartum, T6 12 weeks postpartum, T7 18 months postpartum